Sponsor Pipeline

Alzamend Neuro, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT06921590
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral…		 Trial completed
2026-07-30 NCT06921590
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral…		 Primary endpoint(s) modified
2026-07-30 NCT06921590
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral…		 Enrollment increased: 6 -> 15 participants
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07540338 A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral… Bipolar I Disorder Recruiting
NCT05834296 Study in Subjects With Mild-to-Moderate Alzheimer's Dementia Alzheimer Disease Active, Not Recruiting
Disease Areas
Alzheimer's Disease (1) Bipolar Disorder (1)
Get alerts when Alzamend Neuro, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free